News
Alvotech (ALVO) Q2 2025 Earnings Call Transcript
In terms of operating cash flow, Q2 2025 is the strongest quarter in the history of Alvotech and demonstrates the strength of our core business operations, which is reflected in high product revenue collections during the period and is accomplished while we are still building inventory in preparation of new launches.
Co-Diagnostics( CODX 0.99%) reported a steep revenue decline in Q2 2025, driven by the absence of grant income. Management ...
Advanced Drainage’s Q2 results received a strong positive market reaction, reflecting resilience in a challenging demand ...
Live Updates Live Coverage Has Ended Guidance is In 5:27 pm Here’s what the company said: “Now turning to guidance for Q3 and ...
MCLEAN, VA / ACCESS Newswire / August 11, 2025 / Gladstone Investment Corporation (Nasdaq:GAIN) announces the following event ...
Full-year product gross margin guidance for fiscal 2025 has now been raised to 50%-53%. Licensing revenue-- $3 million in licensing revenue for the nine months ended June 30, 2025, from the Zimmer ...
2d
Lumentum Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
JP Morgan analyst Samik Chatterjee maintained an Overweight rating and boosted the price target from $100 to $123 on July 17, ...
Kolibri Global Energy Inc (KGEI) reports increased production and financial flexibility, despite facing revenue declines due ...
F&B per cap trends -- There was a double-digit percentage increase in food and beverage per caps at The Garden during Q4 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback